Real-time financial, economic, and global news with market-focused context and analysis.
Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.
Evaxion A/S, a clinical-stage TechBio company utilizing its AI-Immunology platform for vaccine development, announces it will release its second quarter 2026 financial results and provide a business update on August 20, 2026. The company will host a conference call and webcast presenting these details to investors and analysts.
Wildfires across multiple parts of Europe have forced large-scale evacuations, caused injuries and severe property damage, and prompted emergency maritime rescues. Officials reported dozens of injured people and thousands displaced as intense heat and drought fuel fast-moving fires. European climate monitoring services warned of widespread 'very ex…
LanzaTech Global, Inc. announced its Q2 2026 financial results showing a slight decline in revenue but substantial improvement in operating expenses and net income driven by cost optimization and unrealized gains from its SGLT investment. The company advanced its position towards pioneering the world's first ISCC EU certification for recycled carbo…
SurgePays, Inc. disclosed strong financial results for Q2 2026, with revenue growing 40.7% year-over-year to $16.2 million, marking the sixth consecutive quarter of sequential revenue growth. The company also achieved a positive net income of $1.29 million, returning to GAAP profitability. First half 2026 revenue rose 45.7% compared to the prior ye…
FirstCash is uniquely positioned to convert macro stress and recent UK acquisitions into outsized earnings and free cash flow growth. At roughly $210 per share today, the stock offers a 5.8% FCF yield and room for multiple expansion as scale, operating leverage and cross-border synergies materialize. This trade idea lays out an entry at $211.00, a …
BridgeBio Pharma announced the pricing of a secondary offering of 5 million shares of common stock by selling shareholder KKR Genetic Disorder L.P. The company itself is not selling shares and will not receive proceeds from this transaction. The offering aims to diversify and evolve BridgeBio's institutional shareholder base toward long-term, high-…
Wrap Technologies has been chosen by WOFT Charities to provide training services for a newly funded $475,000 Teacher Safety Training Program in Florida. This program aims to enhance situational awareness and safety skills among teachers and school personnel, expanding Wrap’s public safety training expertise beyond law enforcement into education.
Super League Enterprise, Inc. announced second quarter 2026 financial results showing sequential net revenue growth of 16%, gross margin expansion to 41%, and a 20% year-over-year improvement in adjusted EBITDA, despite flat gross revenue in a tough advertising environment. The company successfully integrated Misfits Ads assets without raising cost…
Beneficient, a Nasdaq-listed technology-enabled platform for alternative asset liquidity and capital solutions, reported its Q1 FY 2027 results showing progress in strategic initiatives. Key developments include securing its first collateral management services agreement with a Texas state-chartered bank, generating expected recurring fee revenue, …
Diginex Limited announced an extraordinary general meeting scheduled for October 8, 2026, seeking shareholder approval for its proposed acquisition of Resulticks Global Companies. The acquisition consideration involves issuing 600 million new shares of Diginex at $1.75 per share. Additionally, Diginex plans to increase authorized share capital and …
Edible Garden AG Incorporated reported a 12.8% increase in revenue to $3.6 million and a 31.2% increase in total sales for Q2 2026, driven by strong growth in fresh-cut herbs, condiments, and international vitamins. The company expanded retail partnerships, including new distribution agreements with Target, Kroger, and Weis Markets, and progressed …
Milestone Scientific Inc. reported a 22% year-over-year revenue increase for Q2 2026 to $2.8 million, driven by a 231% surge in medical segment sales, particularly CompuFlo®. The company reaffirmed a 2026 outlook of double-digit revenue growth, highlighting strategic distribution agreements expanding access to federal healthcare systems and Medicar…
Helus Pharma reported Q1 Fiscal 2027 results highlighting completion of enrollment in its Phase 3 APPROACH study for HLP003 in Major Depressive Disorder with top-line data expected in Q4 2026. The company appointed Michael Halstead as CEO to lead late-stage development and commercialization efforts. Its Phase 2 candidate HLP004 showed meaningful im…
Wetour Robotics shares spiked sharply in pre-market trading after the company disclosed a new Regulation S private placement and scheduled an Extraordinary General Meeting to vote on another reverse split and a larger authorized share count. The move highlights a classic micro-cap, event-driven setup: renewed liquidity, a near-term binary corporate…
Outlook Therapeutics announced its Q3 fiscal 2026 financial results and detailed progress toward the U.S. commercial launch of LYTENAVA™, the only FDA-approved ophthalmic bevacizumab for wet age-related macular degeneration (wet AMD). The company aims to launch LYTENAVA in the U.S. by the end of 2026 and projects potential annual sales exceeding $5…
Oil climbed on Friday and was positioned to record weekly gains after U.S. officials said a naval blockade of Iran could be maintained indefinitely, stoking concerns about disruptions to Middle East supplies. Brent and U.S. crude rose modestly while traffic through the Strait of Hormuz fell below the month's average. At the same time, forecasts fro…
PowerCompute, a Nasdaq-listed Bitcoin mining and treasury company, reported Q2 2026 revenue growth of 9.8% year-over-year driven by increased Bitcoin mining production despite lower Bitcoin prices. The company expanded strategically into high-performance computing (HPC) and AI infrastructure leveraging its power assets and entered into a GPU comput…
Quantum BioPharma Ltd. reported a stronger liquidity position with cash and equivalents nearly doubling to $3.65 million and total assets increasing to $9.5 million as of mid-2026. The company reduced operating expenses by over 50% year-over-year while extending its cash runway to at least October 2027. Importantly, the FDA approved Quantum's Inves…
Aurora Mobile Limited (NASDAQ: JG) announced a three-year Memorandum of Understanding with Exabytes, a leading AI-driven digital solutions provider in Southeast Asia, to jointly develop and deploy AI-powered customer engagement solutions. The partnership aims to integrate Aurora Mobile’s AI-first platforms, EngageLab and GPTBots.ai, with Exabytes’ …
Fate Therapeutics has initiated the RECLAIM-LN Phase 2 clinical trial of its off-the-shelf FT819 CAR T-cell therapy in patients with refractory moderate-to-severe systemic lupus erythematosus (SLE) with lupus nephritis. The trial, supported by RMAT designation and FDA pilot programs, aims to enroll about 53 patients and evaluate the therapy's safet…
Adlai Nortye Ltd. reported strong operational progress with ongoing enrollment in global Phase I trials for its pan-RAS(ON) inhibitor AN9025 and regulatory approval for Phase I trial of AN4035 ADC. The company raised a total of $290 million in equity financing in early 2026, significantly boosting its cash reserves. Financial results show increased…
Teamshares announced Q2 2026 results showing 20% revenue growth to $148.7 million, net income of $9.5 million, and a 166% increase in Adjusted EBITDA year-over-year. The company reaffirmed its 2026 full-year outlook with a $40 million EBITDA acquisition target, underpinned by a strong pipeline including $30 million annual EBITDA under letters of in…
Neumora Therapeutics reported its second quarter 2026 financial results, highlighting progress in its drug pipeline including favorable preclinical data for NMRA-215 with planned IND submission and Phase 1 study initiation by end of 2026. NMRA-511 and NMRA-898 programs targeting Alzheimer's agitation and schizophrenia are progressing towards clinic…
Tvardi Therapeutics announced its second quarter 2026 financial results and provided a business update highlighting topline healthy volunteer results for its next-generation STAT3 inhibitor, TTI-109, confirming the prodrug design, improved tolerability, and reductions in immune cell populations relevant to ulcerative colitis (UC). The company selec…
Beyond Meat, Inc. has completed a 1-for-30 reverse stock split effective August 13, 2026, reducing the number of outstanding shares and authorized shares to help the company meet Nasdaq's minimum bid price requirement. The adjusted shares will begin trading on August 14, 2026 under the ticker BYND. The reverse split proportionately adjusts conversi…
